Highly Thermotolerant SARS-CoV-2 Vaccine Elicits Neutralizing Antibodies Against Delta and Omicron in Mice. Viruses,Apr 13;14(4):800
3) Ahmed S, Khan MS, Gayathri S, Singh R, Kumar S, Patel UR, Malladi SK, Rajmani RS, van Vuren PJ, Riddell S, Goldie S, Girish N, Reddy P, Upadhyaya A, Pandey S, Siddiqui S, Tyagi A, Jha S, Pandey R, Khatun O, Narayan R, Tripathi S, McAuley A, Balasubramanian NS, Vasan SS, Ringe RP, Varadarajan R. (2021)
A stabilized, monomeric, Receptor Binding Domain elicits high-titer neutralizing antibodies against all SARS-CoV-2 variants of concern. Frontiers in Immunology, Dec 9;12:765211
4) Mittal N, Sengupta N, Malladi SK, Reddy P, Bhat M, Rajmani RS, Sedeyn K, Saelens X, Dutta S, Varadarajan R. (2021)
Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions. Viruses, 13(9):1710
5) Malladi SK, Patel UR, Rajmani RS, Singh R, Pandey S, Kumar S, Khaleeq S, van Vuren PJ, Riddell S, Goldie S, Gayathri S, Chakraborty D, Kalita P, Pramanick I, Agarwal N, Reddy P, Girish N, Upadhyaya A, Khan MS, Kanjo K, Bhat M, Mani S, Bhattacharyya S, Siddiqui S, Tyagi A, Jha S, Pandey R, Tripathi S, Dutta S, McAuley AJ, Singanallur NB, Vasan SS, Ringe RP, Varadarajan R
Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative. ACS infectious diseases,7(8), 2546-2564
6) Pramanick I, Sengupta N, Mishra S, Pandey S, Girish N, Das A, Dutta S
Conformational flexibility and structural variability of SARS-CoV2 S protein. Structure. 2021 Aug 5;29(8):834-845.e5. doi: 10.1016/j.str.2021.04.006. Epub 2021 Apr 30
7) Malladi SK, Singh R, Pandey S, Gayathri S, Kanjo K, Ahmed S, Khan MS, Kalita P, Girish N, Upadhyaya A, Reddy P, Pramanick I, Bhasin M, Mani S, Bhattacharyya S, Joseph J, Thankamani K, Raj VS, Dutta S, Singh R, Nadig G, Varadarajan R. (2020)
Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment. Journal of Biological Chemistry. doi: 10.1074/jbc.RA120.016284
